SCHEMBL5692416

SCHEMBL5692416

Cc1cc(C=O)ccc1OCC(=O)N1CCOCC1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.77
▸ KDM4E B2RXH2 5/20 0.60
▸ GAA P10253 2/20 0.58
▸ SMN1; SMN2 Q16637 4/20 0.57
▸ FKBP1A P62942 3/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ KMT2A Q03164 2/20 0.57
▸ HPGD P15428 4/20 0.56
▸ RAB9A P51151 2/20 0.56
▸ NPC1 O15118 2/20 0.56
▸ GLA P06280 1/20 0.56
▸ MITF O75030 1/20 0.54
▸ MAPT P10636 1/20 0.54
▸ MAPK1 P28482 1/20 0.54
▸ HTT P42858 1/20 0.54
▸ CACNA1B Q00975 1/20 0.54
▸ APBA1 Q02410 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ TSHR P16473 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31428602 0.87 ALDH1A1 (1.00) ALDH1A1KDM4EGAASMN1; SMN2FKBP1A
SCHEMBL5692309 0.87 ALDH1A1 (1.00) ALDH1A1KDM4EGAASMN1; SMN2FKBP1A
SCHEMBL5692383 0.86 KDM4E (0.61) ALDH1A1KDM4EGAASMN1; SMN2MEN1
SCHEMBL30163498 0.82 ALDH1A1 (0.69) ALDH1A1KDM4EGAASMN1; SMN2FKBP1A
SCHEMBL5692472 0.79 ALDH1A1 (1.00) ALDH1A1KDM4EGAASMN1; SMN2FKBP1A
SCHEMBL5066050 0.79 LMNA (0.60) ALDH1A1KDM4EGAASMN1; SMN2MEN1
SCHEMBL5692621 0.79 POLB (0.56) ALDH1A1KDM4ESMN1; SMN2MEN1KMT2A
SCHEMBL528448 0.78 ALDH1A1 (0.72) ALDH1A1KDM4ESMN1; SMN2FKBP1AKMT2A
SCHEMBL5692506 0.77 ALDH1A1 (0.49) ALDH1A1KDM4EGAASMN1; SMN2FKBP1A
SCHEMBL5692515 0.77 ALDH1A1 (0.49) ALDH1A1KDM4EGAASMN1; SMN2FKBP1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060281789-A1 Protein kinase inhibitors KYOWA HAKKO KOGYO CO., LTD (JP) 2006-12-14 — — US disclosed
EP-1650194-A1 PROTEIN KINASE INHIBITOR KYOWA HAKKO KOGYO CO., LTD. (JP) 2006-04-26 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060281789-A1 Protein kinase inhibitors MAP3K20, MAP3K1, MAP3K19 ALDH1A1 2999/4885KDM4E 1355/4885GAA 3649/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback